Rigano · Journal of comparative physiology. B, Biochemical, systemic, and environmental physiology 2017 · Animal physiological and in vitro experimental study · n=?

Life in the fat lane: seasonal regulation of insulin sensitivity, food intake, and adipose biology in brown bears.

Cited 87 times in the scientific literature.

Level 5 - mechanism / opinion, no new human data

Animal physiology and in vitro experimental study

PubMed 27987017 · doi:10.1007/s00360-016-1050-9 · record verified 2026-08-29

What was done

Captive grizzly bears (*Ursus arctos horribilis*) were evaluated across seasons using insulin and glucose tolerance tests, annual circulating adipokine and glycerol profiling, and central leptin administration assays in August versus October alongside hypothalamic phosphorylated STAT3 immunohistochemistry. Isolated bear gluteal adipocytes were also cultured in vitro with active-season or hibernation serum (including heat-treated serum) to test insulin and beta-adrenergic sensitivity.

What was found

Bears were insulin resistant during hibernation but sensitive during the spring and fall active periods. Hibernating bears remained euglycemic, accompanied by hyperinsulinemia and hyperglucagonemia. Circulating adipokines peaked in mid-October, and serum glycerol was highest during hibernation. Centrally administered leptin decreased food intake in October but not in August, matching strong hypothalamic phosphorylated STAT3 labeling during hibernation that disappeared during the active season. Cultured hibernating adipocytes regained insulin sensitivity when exposed to active-season serum, an effect largely blocked by heat treatment. No exact quantitative values or statistical metrics were reported in the abstract.

Why it matters

This study demonstrates that seasonal obesity in grizzly bears involves reversible shifts in central leptin sensitivity and circulating serum-dependent insulin signaling without typical obesity-related pathology.

Limits

The study is limited to captive animal models and in vitro cellular assays, precluding direct clinical translation. Sample sizes, quantitative concentrations, effect sizes, and variance were not reported in the abstract.

Cited by